Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🗓️ Plan for Wealth: Key market movers that could make (or break) your week
See Economic Calendar
Search Results for "PBYI":
Results: 274
News
Puma Biotech earnings beat by $0.16, revenue topped estimates
By Investing.com
Investing.com - Puma Biotech (NASDAQ: PBYI) reported second quarter EPS of $0.190, $0.16 better than the analyst estimate of $0.030. Revenue for the quarter came in at $56.5M versus the consensus...
Earnings call transcript: Puma Biotechnology tops Q2 2026 estimates as profit returns
By Investing.com
Puma Biotechnology reported stronger-than-expected second-quarter 2026 results, with revenue of $56.5 million and GAAP earnings of $0.16 per diluted share, ahead of Wall Street’s forecast for...
Puma Bio's Nerlynx in treatment guidelines for certain breast cancer patients
By Seeking Alpha
Puma Biotechnology (PBYI -0.7%) announces that NERLYNX (neratinib) is now included in the National Comprehensive Central Network (NCCN) Clinical Practice Guidelines in breast cancer patients with...
Analysis
Puma Biotechnology (PBYI): Moving Average Crossover Alert
By Zacks Investment Research
Are you a technical investor? If so, it may be time to consider Puma Biotechnology, Inc. (NYSE:PBYI) for your portfolio. The company just saw its 50 Day Moving Average breakout above its 200 Day...
Puma (PBYI) Presents Favorable Phase II Data On Neratinib
By Zacks Investment Research
Puma Biotechnology, Inc. (NYSE:ANIP) and Retrophin, Inc. (NASDAQ:RTRX) , each sporting a Zacks Rank #1 (Strong Buy). ASTRAZENECA PLC (AZN): Free Stock Analysis Report RETROPHIN INC (RTRX): Free...
Puma (PBYI) Stock Up, Phase II Data On Neratinib Published
By Zacks Investment Research
Puma Biotechnology, Inc. (NYSE:INVA) and Pfizer Inc. (NYSE:PFE) . While Innoviva sports a Zacks Rank #1 (Strong Buy), Pfizer carries a Zacks Rank #2 (Buy). ROCHE HLDG LTD (RHHBY): Free Stock...
Results: 1
Refine Results
Instrument Type
Region
Sector
Industry
- All Industries
- Coal
- Oil & Gas
- Oil & Gas Related Equipment and Services
- Renewable Energy
- Uranium
- Chemicals
- Metals & Mining
- Construction Materials
- Paper & Forest Products
- Containers & Packaging
- Aerospace & Defense
- Machinery, Tools, Heavy Vehicles, Trains & Ships
- Construction & Engineering
- Diversified Industrial Goods Wholesale
- Professional & Commercial Services
- Freight & Logistics Services
- Passenger Transportation Services
- Transport Infrastructure
- Automobiles & Auto Parts
- Textiles & Apparel
- Homebuilding & Construction Supplies
- Household Goods
- Leisure Products
- Hotels & Entertainment Services
- Media & Publishing
- Diversified Retail
- Specialty Retailers
- Beverages
- Food & Tobacco
- Personal & Household Products & Services
- Food & Drug Retailing
- Consumer Goods Conglomerates
- Banking Services
- Investment Banking & Investment Services
- Insurance
- Collective Investments
- Investment Holding Companies
- Healthcare Equipment & Supplies
- Healthcare Providers & Services
- Pharmaceuticals
- Biotechnology & Medical Research
- Semiconductors & Semiconductor Equipment
- Communications & Networking
- Electronic Equipment & Parts
- Office Equipment
- Computers, Phones & Household Electronics
- Integrated Hardware & Software
- Software & IT Services
- Financial Technology (Fintech) & Infrastructure
- Telecommunications Services
- Electrical Utilities & IPPs
- Natural Gas Utilities
- Water & Related Utilities
- Multiline Utilities
- Real Estate Operations
- Residential & Commercial REITs
- Institutions, Associations & Organizations
- Government Activity
- Miscellaneous Educational Service Providers
- School, College & University
- Professional & Business Education
Quotes
Results: 139
Refine Results
Date
Date
Category
Provider
- All Providers
- Reuters
- Investing.com DNA 3rd party news
- Investing.com
- International Business Times
- Yahoo Finance
- FinanceMagnates
- Financial Times
- Forbes
- Bloomberg_video
- Business Insider
- Seeking Alpha
- Financial news 24
- Bloomberg
- DC Forecasts
- Cryptovest
- Cointelegraph
- AMBCrypto
- CoinDesk
- Crypto Globe
- blokt
- test
- The Conversation
- Allrates
- Money Show
- Euronews
- RealVision
- bizportal
- FX Street
- FX Empire
- Investing.com
- Investing.com
- Investing.com
- Crunchbase
- CoinEdition
- DailyCoin
- StockNews
- U.Today
- Investing.com
- Crypto.news
- Investing.com
- Quiver Quantitative
- Stock Story
- Chainwire
- CME Group
- Yolowire.com
- Bitcoin World
- FinanceWire
- TEST
- PR Desk
- PulseBulletin.com
- Pinion Newswire
- Live Bitcoin News
- Bitwire
- Press Desk
- Coinzilla
News
Please try another search
Results: 134
Analysis
Results: 0
Tools & Sections
Results: 0
Authors
- Sign up for FREE and get:
- Real-Time Alerts
- Advanced Portfolio Features
- Personalized Charts
- Fully-Synced App